FDA Chief Counsel Daniel Troy Resigns

[Guest guest]

One rat gone. Let's all celebrate. Who's next?

 

Don't you just love Sidney Wolfe's comments!!!

Gee, could his resignation also be about the FDA

doesn't offer attractive stock options or Big

Pharma perks? Follow the money ... ah, yes.

 

Just me... Jan

======================================

..

Still, critics said Troy's past work on behalf of drug

companies raised questions about his true loyalties.

 

Families of children who died after using antidepressants

that heightened their suicidal thoughts and behaviors

blamed Troy for siding with drug companies that minimized

the risks.

 

Consumer advocate Sidney Wolfe said, " I'm sure he's

eager to return working for a law firm that does an even

better job serving the companies he knows and loves so

well. "

 

Rep. Maurice Hinchey, D-N.Y., chided Troy for siding with

the industry after consumers filed lawsuits regarding

FDA-approved products.

 

" Troy has worked in cooperation with the manufacturers,

ignoring serious conflicts of interests, " Hinchey said in a

statement.

 

 

http://www.kansascity.com/mld/kansascity/news/politics/10198297.htm?1c

 

Posted on Tue, Nov. 16, 2004

 

" FDA Chief Counsel Daniel Troy Resigns "

DIEDTRA HENDERSON

Associated Press

 

WASHINGTON - Daniel E. Troy, chief counsel for the

Food and Drug Administration, resigned Tuesday with

plans to return to the private sector.

 

Troy, 44, took over as the FDA's senior legal adviser

in August 2001.

 

" More than three years passed. And we won the election.

And that's about the amount of time that I intended to

serve, " Troy said. His resignation takes effect Nov. 28.

 

Lester Crawford, FDA acting commissioner, accepted

the resignation with " mixed emotions, " according to a

statement.

 

Troy " has served the agency with tireless dedication.

Shortly after Dan's arrival, he faced a major challenge,

assisting the Agency in addressing the myriad public

health dimensions of the terrorist attacks of September

11, 2001. Thereafter, he provided excellent legal

support to the agency as we responded to the anthrax

attacks and reoriented the agency to its new counter

terrorism responsibilities, " Crawford said.

 

Troy also helped the FDA speed access to generic

drugs. And he helped settle First Amendment questions,

encouraging the FDA to allow conventional foods to carry

limited health claims.

 

Still, critics said Troy's past work on behalf of drug

companies raised questions about his true loyalties.

 

Families of children who died after using antidepressants

that heightened their suicidal thoughts and behaviors

blamed Troy for siding with drug companies that minimized

the risks.

 

Consumer advocate Sidney Wolfe said, " I'm sure he's

eager to return working for a law firm that does an even

better job serving the companies he knows and loves so

well. "

 

Rep. Maurice Hinchey, D-N.Y., chided Troy for siding with

the industry after consumers filed lawsuits regarding

FDA-approved products.

 

" Troy has worked in cooperation with the manufacturers,

ignoring serious conflicts of interests, " Hinchey said in a

statement.

 

Troy responded: " I have represented the law. And know

where the law favored a particular position. "

 

Troy said he and his family will remain in Chevy Chase, Md.,

but was unclear about his future employment. Government

rules preclude him from appearing before the agency,

having his name on a legal brief or making contact with the

FDA on behalf of a client for one year.

 

" I've not accepted a job. I've not even interviewed for

a job. I'm not going to interview for a job until after I

leave this job, " he said. " But I plan to return to private

practice. "

 

Jerry Masoudi, current deputy associate general counsel,

will become acting FDA chief counsel until a permanent

replacement is appointed.

 

========

========

..

..